InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Horan Christopher. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. Cumulatively, 6 disclosures have been recorded. Activity tracked since 12 September 2024. The latest transaction was disclosed on 15 February 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Horan Christopher is a declarant linked to Artiva Biotherapeutics, Inc., where he is Chief Tech Operations Officer. The record shows 6 filings in total, and across the 6 sampled filings the period runs from 2024-09-13 to 2026-02-18, with buy and sell amounts at 0 and transactions of Attribution nature.